Financials
Financial year 2025
PHARMACIE BASILIQUE from Koekelberg, company number BE0821770142, closed financial year 2025 with a result of € 26,699 after tax. For that financial year PHARMACIE BASILIQUE recorded a gross margin of € 37,594 and equity of € 166,326. Compared with financial year 2024, the result moved from € 10,845 to € 26,699. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 10, 2026.
€ 166,326
▲ 19% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 26,699
▲ 146% vs 2024
Profit after tax over the fiscal year.
€ 43,541
▼ 48% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 117,561.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 31,345
▲ 7% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 3,299
▲ € 3,271 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 74,821 | € 62,665 | € 51,046 | € 37,594 | ▼ 26% |
| Profit after taxes | € 26,353 | € 10,215 | € 10,845 | € 26,699 | ▲ 146% |
| Equity | € 333,567 | € 128,782 | € 139,627 | € 166,326 | ▲ 19% |
| Total debts | € 199,979 | € 420,151 | € 30,345 | € 34,645 | ▲ 14% |
| Cash | € 425,002 | € 445,586 | € 84,262 | € 43,541 | ▼ 48% |
| Retained profit | € 183,567 | € 80,016 | € 90,861 | € 117,561 | ▲ 29% |
| Dividend | € 0 | € 113,765 | € 0 | € 0 | |
| Balance sheet total | € 533,546 | € 548,933 | € 169,972 | € 200,971 | ▲ 18% |
| Employees (FTE) | - | - | 0.5 | - |
Key figures of PHARMACIE BASILIQUE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE BASILIQUE?
What happened at PHARMACIE BASILIQUE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 26,699 (▲ 146% vs 2024). filed late Source: NBB ↗
- SENTELYS PHARMA SRL became a director. NBB
- New establishment in Koekelberg. KBO
- Start of the company according to the CBE. KBO
In short
From € 26,353 profit in 2022 to € 26,699 profit in 2025.
Paid € 23,410 in corporate taxes since 2022.
Best year ever: 2025, with € 26,699 profit.
Paid out € 113,765 in dividends to the owners in total.
A new publication or filing at PHARMACIE BASILIQUE? We notify you, reason included.
Follow PHARMACIE BASILIQUEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of SENTELYS PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE BASILIQUEBehind PHARMACIE BASILIQUE is SENTELYS PHARMA SRL. The shares are held by SENTELYS PHARMA (100%).
Directors
According to the 2025 annual accounts
Director · represented by TAFRANTI ASMAH
since 2024
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Sint-Agatha-Berchemselaan 7
1081 Koekelberg
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0821.770.142
- VAT number
- BE 0821.770.142
- Registered office
- Sint-Agatha-Berchemselaan 7, 1081 Koekelberg
- Names & denominations
- PHARMACIE BASILIQUE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 December 2009
- Peppol
- Active · Active since 3 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten